Request Demo
Last update 04 Mar 2026
Bard Pharmaceuticals Ltd.
Last update 04 Mar 2026
Overview
Related
CTR20130159
羟考酮/纳洛酮缓释片相比羟考酮缓释片可改善中重度非癌疼痛患者便秘症状-羟考酮当量10-50 mg/天
[Translation] Oxycodone/naloxone extended-release tablets improve constipation symptoms in patients with moderate to severe non-cancer pain compared with oxycodone extended-release tablets - oxycodone equivalent 10-50 mg/day
CTR20192045
羟考酮/纳洛酮缓释片与羟考酮缓释片治疗中度到重度慢性癌痛患者中安全性有效性随机双盲双模拟平行分组研究
[Translation] A randomized double-blind, double-dummy, parallel-group study on the safety and efficacy of oxycodone/naloxone extended-release tablets and oxycodone extended-release tablets in the treatment of moderate to severe chronic cancer pain
100 Clinical Results associated with Bard Pharmaceuticals Ltd.
Login to view more data
Login to view more data
100 Deals associated with Bard Pharmaceuticals Ltd.
Login to view more data
100 Translational Medicine associated with Bard Pharmaceuticals Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 17 Mar 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free